Concepedia

Enrico Breda

EB

Statistics

Publications

39

Citations

2.6K

H-Index

26

Active since

2003

Affiliations

Università Cattolica del Sacro Cuore(Current)

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Fatebenefratelli Hospital

Centro di Riferimento Oncologico

Istituti di Ricovero e Cura a Carattere Scientifico

Enrico Breda is an author at Università Cattolica del Sacro Cuore specializing in medicine, obstetrics, and gynecology oncology.

ORCID

Top concepts

Publications per year

2003–2021

39

Publications

39

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial

Sandro Pignata, Giovanni Scambia, Dionyssios Katsaros et al. · The Lancet Oncology · 2014 · 386 citations

, , +7

Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer

Gabriella Ferrandina, M. Ludovisi, Domenica Lorusso et al. · Journal of Clinical Oncology · 2008 · 295 citations · Full text

Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial

Sandro Pignata, Giovanni Scambia, Gabriella Ferrandina et al. · Journal of Clinical Oncology · 2011 · 212 citations · Full text

Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary

Giorgia Mangili, Jessica Ottolina, Angiolo Gadducci et al. · British Journal of Cancer · 2013 · 163 citations · Full text

Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial

Sandro Pignata, Domenica Lorusso, Florence Joly et al. · The Lancet Oncology · 2021 · 144 citations

, , +7

1–5 of 39